]>
IRCT20200405046960N1 IRCT 2020-04-08 Ardabil University of Medical Sciences Efficacy of Kelofan syrup on COVID-19 - Evaluating efficacy of Kelofan syrup, a traditional Iranian medicine product, on pulmonary and other clinical and laboratory manifestations of patients with probable or confirmed COVID-19 2020-04-09 anticipated 15 Complete https://irct.ir/trial/46961 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 1-2 Condition 1: COVID-19. Condition 2: COVID-19. In the intervention group, in addition to the standard treatment, medicinal herbal products will be prescribed. The drug will be given in syrup form. The syrup will contain the following medicinal herbs: Nepeta bracteata، Adiantum capillus veneris، Glycyrrhi za glabra, Foeniculum vulgare، Viola odorata, Ziziphus jujube, Malva sylvestris, Nigella sativa . The intervention group will receive 7.5 cc of Kelofan syrup every 12 hours for one week.. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information
public Ramin Nasimi Doost Azgomi
Ardabil University of Medical Sciences; Daneshgah street
Ardabil Iran (Islamic Republic of) 5618985991 +98 45 3142 2529 modir7060@yahoo.com Ardabil University of Medical Sciences scientific Ramin Nasimi Doost Azgomi
Ardabil University of Medical Sciences; Daneshgah street
Ardabil Iran (Islamic Republic of) 5618985991 +98 45 3142 2529 Modir7060@yahoo.com Ardabil University of Medical Sciences Iran (Islamic Republic of) Patients over 18 years old Hospitalized patients with probable or confirmed COVID-19 based on radiological findings or positive PCR test according to the instructions of the Ministry of Health Clinically classified as moderate and severe, no need for intubation Written and informed satisfaction of patients 18 years no limit Both Liver, kidney and heart failure History of allergies to medicinal herbs Immunodeficiency Hypertension Diabetes Alcohol or drug addiction Patients with transplanted organs Cor Pulmonel Patients Taking anticoagulants, antiarrhythmics, antihypertensives, corticosteroids and immunosuppressants Pregnancy Breast feeding U07.1 U07.2 COVID19, virus identified COVID19, virus not identified Treatment - Drugs In the intervention group, in addition to the standard treatment, medicinal herbal products will be prescribed. The drug will be given in syrup form. The syrup will contain the following medicinal herbs: Nepeta bracteata، Adiantum capillus veneris، Glycyrrhi za glabra, Foeniculum vulgare، Viola odorata, Ziziphus jujube, Malva sylvestris, Nigella sativa . The intervention group will receive 7.5 cc of Kelofan syrup every 12 hours for one week. Oxygen saturation. Timepoint: Clinical examination and Pulse Oximetry before starting medication and regularly during treatment. Method of measurement: Pulse Oximeter. Respiratory Rate. Timepoint: Clinical examination before starting medication and regularly during treatment. Method of measurement: Respiratory Count. C-reactive protein. Timepoint: Intravenous blood testing before starting medication and during treatment. Method of measurement: Venous blood test. Lymphocytes. Timepoint: Intravenous blood testing before starting medication and during treatment. Method of measurement: Venous blood test. White Cell blood count. Timepoint: Intravenous blood testing before starting medication and during treatment. Method of measurement: Venous blood test. Liver enzymes. Timepoint: Intravenous blood testing before starting medication and during treatment. Method of measurement: Venous blood test. Ardabil University of Medical Sciences Approved 2020-04-05 Ethics committee of Ardabil University of Medical Sciences Ardabil University of Medical Sciences; Daneshgah street Ardabil Ardabil Iran (Islamic Republic of)